🇺🇸 FDA
Patent

US 8642550

Chimeric natriuretic peptides without hypotensive inducing capability

granted A61KA61K38/00

Quick answer

US patent 8642550 (Chimeric natriuretic peptides without hypotensive inducing capability) held by Regents of the University of Minnesota expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00